Shilpa Medicare gets USFDA warning letter for Telangana facility; stock down over 7%

The company believes that the warning letter will have the minimum impact of disruption of supplies and the existing revenues from operations of this facility.

from India Infoline News Service https://ift.tt/34IbkZ2